Marvelon (Desogestrel, Ethinylestradiol)

Marvelon, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

• Contraception: Provides reliable prevention of pregnancy when taken as directed.
• Menstrual cycle regulation: Helps achieve more regular menstrual bleeding patterns.
• Acne management: May improve acne associated with hormonal fluctuations.

• Desogestrel and ethinylestradiol act synergistically to suppress the hypothalamic‑pituitary‑ovarian axis. Desogestrel, a progestogen, inhibits the luteinizing hormone surge, preventing ovulation, while ethinylestradiol, an estrogen, stabilises the endometrial lining and increases cervical mucus viscosity, creating an environment hostile to sperm penetration and implantation.

Marvelon may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild stomach upset, often resolves with continued use.
• Breast tenderness: temporary swelling or discomfort.
• Headache: mild to moderate intensity.
• Spotting or breakthrough bleeding: irregular bleeding between periods.
• Mood changes: irritability or mild mood swings.
• Weight fluctuation: slight increase or decrease.

Serious or Rare Side Effects

• Deep vein thrombosis: blood clot formation in the legs.
• Pulmonary embolism: clot migration to the lungs.
• Stroke: interruption of cerebral blood flow.
• Myocardial infarction: heart attack risk, especially in smokers.
• Severe allergic reaction: rash, swelling, or anaphylaxis.
• Liver tumor: rare hepatic adenoma development.

Before prescribing Marvelon, clinicians should evaluate individual risk factors and contraindications.

• Contraindicated in pregnancy: product is classified Category X and must not be used.
• Smoking over age 35: women who smoke heavily should avoid use due to increased thrombotic risk.
• History of thromboembolism: prior clotting events contraindicate therapy.
• Liver disease: severe hepatic impairment requires caution.
• Drug interactions: review concomitant medications for potential efficacy reduction.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Marvelon can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive efficacy.
• Rifampin or rifabutin: strong hepatic enzyme inducers that lower hormone levels.
• Certain antiretrovirals (e.g., efavirenz): can diminish contraceptive protection.

Moderate Interactions (Monitor Closely)

• Antibiotics such as tetracycline or fluoroquinolones: may slightly decrease effectiveness.
• Antifungal agents (e.g., ketoconazole, itraconazole): can increase hormone concentrations, raising side‑effect risk.
• St. John’s wort: herbal inducer that may lower plasma hormone levels.